These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2150637)

  • 21. Vasorelaxant and antihypertensive effects of methanolic extract from roots of Laelia anceps are mediated by calcium-channel antagonism.
    Vergara-Galicia J; Ortiz-Andrade R; Rivera-Leyva J; Castillo-España P; Villalobos-Molina R; Ibarra-Barajas M; Gallardo-Ortiz I; Estrada-Soto S
    Fitoterapia; 2010 Jul; 81(5):350-7. PubMed ID: 19879929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium antagonists in experimental atherosclerosis. Use-dependence of isradipine: a potential explanation for enhanced action in atherosclerotic animals and tissue selectivity.
    Hof RP; Rüegg UT
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):107S-113S. PubMed ID: 1826999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isradipine (Lomir) in the treatment of hypertension. An international satellite symposium of the Vth International Congress on Pulmonary Circulation. Prague, July 6, 1989. Proceedings.
    Cor Vasa; 1990; 32(2 Suppl 1):1-80. PubMed ID: 2143457
    [No Abstract]   [Full Text] [Related]  

  • 24. Review of the international literature on isradipine in hypertension (Lomir/Dynacirc).
    Soland FX
    Cor Vasa; 1990; 32(2 Suppl 1):61-72. PubMed ID: 2143461
    [No Abstract]   [Full Text] [Related]  

  • 25. [Isradipine in arterial hypertension in motor vehicle drivers].
    Aramisova RM; El'garov AA
    Med Tr Prom Ekol; 1996; (8):21-3. PubMed ID: 8963604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central hemodynamics and brachial artery compliance during therapy with isradipine, a new calcium antagonist.
    Andersson OK; Persson B; Widgren BR; Wysocki M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S87-9. PubMed ID: 1695312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transduction pathways for noradrenaline-induced modulation of calcium channels in vascular smooth muscle.
    Mironneau J
    Jpn J Pharmacol; 1992; 58 Suppl 2():87P-95P. PubMed ID: 1324371
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-atherogenic activity of the calcium channel blocker isradipine (PN-200-110): a novel effect on matrix synthesis independent of calcium channel blockade.
    Heider JG; Weinstein DB; Pickens CE; Lan S; Su CM
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):96-101. PubMed ID: 2956747
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heart.
    Hof RP; Salzmann R; Siegl H
    Am J Cardiol; 1987 Jan; 59(3):30B-36B. PubMed ID: 2949586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The calcium antagonist isradipine and its effect on blood pressure related to plasma renin activity.
    Carr AA; Prisant LM
    Am J Hypertens; 1990 May; 3(5 Pt 1):354-9. PubMed ID: 2140943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
    Allikmets K; Parik T; Teesalu R
    Angiology; 1997 Nov; 48(11):977-83. PubMed ID: 9373050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of Ca2+ channels in smooth muscle.
    Mironneau J
    Z Kardiol; 1991; 80 Suppl 7():43-6. PubMed ID: 1665262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel blockers and smooth muscle motility in vitro.
    Gintautiene K; Matook AE; Abadir AR; Estafan MY; Bhangdia P; Silverstein JH; Gintautas J
    Proc West Pharmacol Soc; 1987; 30():141-3. PubMed ID: 3628266
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of the potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes.
    Miyakoda G; Nakayama N; Matsui K; Yabuuchi Y
    Arzneimittelforschung; 1995 Apr; 45(4):471-5. PubMed ID: 7779144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive and vasorelaxant activities of Laelia autumnalis are mainly through calcium channel blockade.
    Vergara-Galicia J; Ortiz-Andrade R; Castillo-España P; Ibarra-Barajas M; Gallardo-Ortiz I; Villalobos-Molina R; Estrada-Soto S
    Vascul Pharmacol; 2008 Jul; 49(1):26-31. PubMed ID: 18534917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isradipine in hypertension.
    Hansson L
    Drugs; 1990; 40 Suppl 2():10-4. PubMed ID: 2150633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo and in vitro effects of cicletanine in spontaneously hypertensive rats.
    Auguet M; Guillon JM; Delaflotte S; Le Hegarat M; Pirotzky E; Clostre F; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):89-95. PubMed ID: 3416727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Calcium antagonists in the treatment of arterial hypertension].
    Raczka A
    Pol Tyg Lek; 1983 Jan; 38(3):95-7. PubMed ID: 6866828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.